Document Detail


Systemic therapies in managing sinonasal inflammation.
MedLine Citation:
PMID:  20525510     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic rhinosinusitis (CRS) is a condition characterized by persistent inflammation due to intrinsic mucosal hypersensitivity or persistent infection. Proper medical treatment with antibiotic, leukotriene modifiers, oral corticosteroids, or even aspirin desensitization for the sinus inflammation can prevent the need for surgical intervention. The key to delineating the specific medical application is to determine the cause of the sinus mucosa dysfunction and its specific inflammatory pathway. Such targeted antiinflammatory medical therapy will lead to improved efficacy in the management of CRS. Even if surgical intervention is required, postoperative medical treatment is essential to minimizing the intrinsic mucosal inflammation and therefore preventing revision endoscopic procedures.
Authors:
Michael A DeMarcantonio; Joseph K Han
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Otolaryngologic clinics of North America     Volume:  43     ISSN:  1557-8259     ISO Abbreviation:  Otolaryngol. Clin. North Am.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-07     Completed Date:  2010-09-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0144042     Medline TA:  Otolaryngol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  551-63, ix     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, 600 Gresham Drive, Suite 1100, Norfolk, VA 23507, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use
Combined Modality Therapy
Drug Therapy / methods*
Eosinophils
Histamine Antagonists / therapeutic use
Humans
Hydroxyurea / analogs & derivatives,  therapeutic use
Immunologic Factors / therapeutic use
Leukotriene Antagonists / therapeutic use
Otorhinolaryngologic Surgical Procedures / methods*
Rhinitis / complications*,  drug therapy*,  surgery
Sinusitis / complications*,  drug therapy*,  surgery
Tosyl Compounds / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Histamine Antagonists; 0/Immunologic Factors; 0/Leukotriene Antagonists; 0/Tosyl Compounds; 107753-78-6/zafirlukast; 127-07-1/Hydroxyurea; 132880-11-6/zileuton

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel Topical Therapeutics.
Next Document:  Application of Minimally Invasive Endoscopic Sinus Surgery Techniques.